• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Phastar Appoints Chris Schoonmaker as Chief Operations Officer

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills

    Batavia Enters Commercial Manufacturing Business

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Vector Partners Limited

    Quotient Sciences

    IDT Biologika

    Kyongbo Pharmaceutical

    CMC Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vector Partners Limited

    Quotient Sciences

    IDT Biologika

    Kyongbo Pharmaceutical

    CMC Pharmaceuticals
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Manufacturing Equipment Trends

    Andreas Mattern of Syntegon Technology discusses latest technologies being leveraged in manufacturing equipment today.

    Manufacturing Equipment Trends
    Photo courtesy of Syntegon
    Related CONTENT
    • Legacy Pharma Solutions
    • Vio Chemicals
    • Sensum
    • WuXi AppTec
    • ViscoTec America Inc.
    Kristin Brooks02.25.21
    The pharmaceutical industry is beholden to the strictest requirements for manufacturing and the equipment used must comply with good manufacturing practices (GMPs). As drug development trends change, so too must manufacturing processes, much of which can now be automated. Andreas Mattern, Ph.D., Director of Product Management Pharma for Syntegon Technology, discusses how the pandemic has impacted equipment needs, the latest technologies being leveraged in manufacturing equipment, as well as the continued challenges and where have advances been made across Cell and Gene manufacture, Single Use Technologies, Continuous Manufacturing, and Digital Technologies.

    What are the latest pharma/biopharma trends impacting manufacturing equipment?
     
    Andreas Mattern: The fight against Covid-19 was the dominant topic in 2020 and will continue to be so for at least the coming months. The demand includes basically everything from laboratory services to processing, fill-finish equipment, inspection technology to services.
     
    Apart from Covid-19, biotechnologically produced drugs, for example for the treatment of cancer, autoimmune diseases, or rare diseases affecting only a small patient population, are still being developed in large numbers and call for ever smaller batch sizes and highly flexible equipment. This trend is accompanied by the need for the highest product quality and protective measures. Containment technologies are highly requested, not only for liquid fill-finish lines, but also increasingly for oral solid dosage (OSD) forms. Here, containment equipment has the very important task of protecting operators from increasingly toxic substances.
     
    Digitalization and automation are further trending topics in the pharmaceutical industry. For example, the use of robots in liquid filling operations reduces the risk of contamination through human contact. Robots offer a high degree of flexibility in manufacturing processes. Machine operators no longer need to perform repetitive tasks, which makes processes safer, more precise, reproducible and validatable. In the future, more and more robotic solutions will be used; the boundaries will continue to shift due to decreasing costs and new technologies such as Artificial Intelligence (AI).
     

    Syntegon Inspection Deep Learning
    The latter is already being used for the visual inspection of pharmaceutical liquids. In fact, Syntegon recently installed the first fully validated visual inspection system utilizing AI in a fully automated machine in a customer’s production line. AI applications have the potential of further increasing detection rates and decreasing the number of false rejects in difficult products like highly viscous parenteral solutions with air bubbles, which are sometimes hard to differentiate from harmful particles. The required Deep Learning vision applications are already available. What they need is profound pharmaceutical and software knowledge to adapt them for pharmaceutical purposes, which essentially also includes validation.
     
    Another trend, which is related but not limited to the challenges of Covid-19, consists in digital service offerings. For example, many customers use remote services when they need assistance with machine settings or troubleshooting.
     
    How has the pandemic impacted equipment needs?                 
     
    AM: The corona crisis presents enormous challenges to the pharmaceutical industry. For example, more than 1,200 clinical trials have been delayed or stopped, according to Globaldata. On the other hand, more than 1,800 vaccines and drugs against Covid-19 are currently being investigated in over 4,000 clinical trials. Existing laboratory and manufacturing capacities must accordingly be reallocated or rebuilt in record time. For contract manufacturers, this need has resulted in an order increase of at least 200% in the infectious disease segment in 2020 compared to 2019.   
     
    Many of the publicly known producers and developers of Covid-19 vaccines and active ingredients for the treatment of corona patients use Syntegon technologies. These include formulation systems, filling lines especially for vial filling, and inspection machines. Among our customers are the largest vaccine manufacturers worldwide. In total, Syntegon solutions for the production of classical vaccines are used more than 100 times by different customers worldwide. Our experience with biotechnological drugs also enables us to support in the production of novel mRNA vaccines with cold filling. Inspection machines from Syntegon are in fact already used in the production process of mRNA Covid vaccines.
     
    Our service has specialized in spare parts and format parts for converting customer facilities for Covid-19 vaccines and therapies. We have also reworked used machines available on the market and upgraded them to meet the new and current requirements in record time.
     
    For us and our customers, the challenge is the speed in which new facilities must be built and existing production capacities converted without jeopardizing product quality and safety. We have also developed and pre-tested modular concepts for vaccine production, such as the SVP process system from Syntegon’s product brand Pharmatec, to enable faster delivery and production on the customer side. We can offer pre-configured full vaccine production lines from formulation to inspection with very fast delivery times to meet the increasing demand for a global vaccination program.
     
    What are the latest technologies being leveraged in manufacturing equipment?
     
    AM: Digital Services: Syntegon introduced a number of new digital services. One of them is MIRA (Machine Intelligence Reporting & Analytics), which was developed especially for predictive maintenance. Leveraging intelligent algorithms, the modular software solution detects wear and tear on process-critical components such as fans. Up to six weeks before a potential failure, it announces that a component needs replacing. The system does not intervene with the machine controls and retrofitted systems do not have to be re-qualified and validated.
     
    Robotics and small batch filling: At Syntegon, we currently use robotic solutions primarily for gentle transport of containers, e.g. to avoid glass-to-glass contact. One example is our Flexible Filling Portfolio (FFP), in which our own four-axis robots (Pharma Handling Units) transfer packaging materials from one station to the next. The individual work steps can be changed at any time so that customers can individually adapt the processes depending on the product and packaging material.

    Syntegon Flexible Filling
    Syntegon’s FFP is an individually configurable, modular machine concept for processing small and medium batches. Whether syringes, vials or cartridges: pharmaceutical manufacturers can select the different modules individually and obtain a filling line completely tailored to their needs, including an integrated isolator for aseptic and high-potent active ingredients.
     
    New coater series: Syntegon introduced an entirely new machine series in 2020: the Sepion coater series combines experience of the former Manesty product brand with the expertise in tablet coating and process technology of the Hüttlin product brand. The state-of-the-art equipment for tablet coating enables closed material handling during filling, sampling and emptying. This makes the Sepion coaters suited for the coating of tablets with highly potent active ingredients, as well as for sugar coating. The optimized drum geometry with its sophisticated spraying system offers better guidance of the process air and shorter processing times. Moreover, the coaters feature an automatically adjustable spray arm and ensure high flexibility from 10 to 100 percent batch size.
     
    Lab equipment and services: The new OSD Customer Center Waiblingen, complements Syntegon’s range of specialized laboratories and customer centers for both solid and liquid pharmaceuticals. It includes everything customers need for the formulation, development and production of their OSD forms: from laboratory equipment to production scale machines, TPR tablet presses for mono and bilayer tablets as well as GKF capsule filling machines are available for all formats and products in different cleanroom classes – up to the highest containment level OEB5.
     
    Software developments: Apart from the use of AI in pharmaceutical applications, further software solutions are important for state-of-the-art processes. For example, the new Automated Process Development (APD) tool from Syntegon determines the optimum parameters for capsule filling processes. While such manual evaluations used to take days or even weeks, the APD tool not only achieves faster but also more precise results. It does so by determining correlations between parameters critical to material, quality and processes, thus ensuring a better understanding of the process – which in turn has a positive effect on product quality.
     
    What are the challenges and where have advances been made in these areas?
     
    AM: Cell and gene therapies: Pipeline analyses show an increasing trend towards allogeneic therapies. This correlates with typical batch sizes of several hundred containers. These are larger than personalized autologous therapies and not suitable for manual filling. On the other hand they are too small for traditional filling lines. This gap is closed with the new Syntegon Microbatch gloveless working cell.  


    Syntegon Xelum
    Continuous Manufacturing is an unbroken trend in OSD production. Syntegon has developed a slightly different approach: as opposed to the common complex mass flow rate based approach, excipients and active ingredients are dosed as a discrete mass on both the Xelum production platform and the Xelum R&D unit. This makes it possible to dose even smallest amounts of APIs of less than one percent reliably.

     

     
    Digital Technologies/paperless processes: Advances in digital solutions are still slow in pharma. Serialization has been implemented in nearly all regions. Further digitalization takes time due to the strict regulatory and validation requirements. Still, the pandemic and travel restrictions have boosted the use of digital communication options. Key customer project appointments, such as model presentations and factory acceptance tests, are partly carried out virtually. When it comes to services, Syntegon also accommodates its customers with digital solutions such as remote maintenance and the new MIRA (Machine Intelligence Reporting & Analytics), which was developed especially for predictive maintenance (see details above).


    Andreas Mattern, Ph.D., is Director Product Management Pharma for Syntegon Technology, a leading global process and packaging technology provider with 6,100 employees at 30 locations in more than 15 countries. Headquartered in Waiblingen, Germany, Syntegon (formerly Bosch Packaging Technology), has been providing solutions for production, processing, filling, inspection and packaging of liquid and solid pharmaceuticals for more than 50 years.
    Related Searches
    • validation services
    • Capsules manufacturing
    • antibody therapeutics
    • schizophrenia
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    Vio Chemicals Vio Chemicals
    Sensum Sensum
    WuXi AppTec WuXi AppTec
    ViscoTec America Inc. ViscoTec America Inc.
    Ackley Machine Corporation Ackley Machine Corporation
    Applied Laboratories Applied Laboratories
    PCI Pharma Services PCI Pharma Services
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Boyds Opens US Office in PA Boyds Opens US Office in PA

    Related Content

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Vio Chemicals

      ...
      Ioanna Kazantzidou, Marketing Communications Officer 12.07.21

    • Sensum

      ...
      Marko Sraj, BDM 12.06.21


    • WuXi AppTec

      ...
      Daja Herald, Marketing Director 11.22.21

    • ViscoTec America Inc.

      ...
      Melanie Hintereder, Marketing 11.05.21

      Loading, Please Wait..
      Trending
      • Regulatory Report: Analytical Procedure Development
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • Pfizer, BioNTech Adapt COVID Vax Against Omicron
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Shimadzu Scientific Instruments Extends HQ Campus
      Breaking News
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      • Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      • EQT Private Equity Acquires SPT Labtech from Battery Ventures
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Kensing Acquires Vitae Naturals
      CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
      Shiitake Mushroom Extract Appears Helpful in HPV Infections
      Coatings World

      Latest Breaking News From Coatings World

      Sheboygan Paint Company Adds Rosey Malchow as Customer Experience Manager
      PPG to Announce Second Quarter 2022 Results July 21
      Evonik Unveils Range of Sustainable Liquid Polybutadienes
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
      NovaXS Unveils New Prototype of Needle-Free Injection Therapy Smart Medical Device
      Meddux Opens New Facility in Boulder, Colorado
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      EQT Private Equity Acquires SPT Labtech from Battery Ventures
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Highlights from Paris Packaging Week
      Walgreens Boots Alliance Decides Not to Sell Boots and No7 Beauty Company Businesses
      WWP Beauty Unveils New Packaging Collections in Collaboration with Eastman
      Happi

      Latest Breaking News From Happi

      Evonik Holds Groundbreaking Ceremony for Commercial Rhamnolipid Production Facility
      CHT USA Hosts Groundbreaking Ceremony for $20 Million US Headquarters Expansion
      Azelis Expands Global Flavors & Fragrances Platform with Acquisition in India
      Ink World

      Latest Breaking News From Ink World

      Temporary Content Title
      Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
      Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Sibress launches FADS3D flexo plate measuring device
      Mike Brown appointed VP for Davis-Standard’s Canadian operations
      Constantia Flexibles introduces chemical resistant recycle-ready laminate
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Suominen Launches Hydraspun Reserve
      Richard Knowlson Receives Lifetime Technical Achievement Award
      Skylark Launches Thicker Label Closure Technology in North American
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Tecomet Appoints Bill Dow as President & CEO
      Medacta, InSilicoTrials Partner on Orthopedic Device Development
      Researchers Develop Microfluidic Sensors to Improve Implant Survival Rates
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Avery Dennison Launches New Dual-Frequency RFID Inlay
      Avery Dennison Highlights New Approach to Apparel with ADX Lab
      trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login